Olema

Olema Oncology is a clinical-stage biopharmaceutical company headquartered in San Francisco with operations in Cambridge, Massachusetts, focused on developing targeted therapies for cancer. Founded in 2006, the company works in endocrine-driven cancers, nuclear receptors, and mechanisms of tumor drug resistance, with a stated goal of transforming the metastatic breast cancer treatment paradigm. Its investigational pipeline includes palazestrant (OP-1250), an oral complete estrogen receptor antagonist and selective estrogen receptor degrader advancing through the Phase 3 OPERA program, and OP-3136, a KAT6 inhibitor in Phase 1 clinical trials. Olema trades publicly on the Nasdaq exchange under the ticker OLMA. As a clinical-stage pharmaceutical company, Olema does not currently publish a developer-facing API, developer portal, SDKs, or public API documentation; this profile captures its corporate identity in the API Evangelist network.

Olema is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Oncology, Healthcare, and Pharmaceuticals.

🌐 Visit website 📡 Source on GitHub
7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiopharmaceuticalOncologyHealthcarePharmaceuticalsClinical TrialsLife SciencesBreast Cancer

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/olema: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Olema Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: olema
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/olema.png
name: Olema
description: Olema Oncology is a clinical-stage biopharmaceutical company headquartered in San Francisco with operations in
  Cambridge, Massachusetts, focused on developing targeted therapies for cancer. Founded in 2006, the company works in endocrine-driven
  cancers, nuclear receptors, and mechanisms of tumor drug resistance, with a stated goal of transforming the metastatic breast
  cancer treatment paradigm. Its investigational pipeline includes palazestrant (OP-1250), an oral complete estrogen receptor
  antagonist and selective estrogen receptor degrader advancing through the Phase 3 OPERA program, and OP-3136, a KAT6 inhibitor
  in Phase 1 clinical trials. Olema trades publicly on the Nasdaq exchange under the ticker OLMA. As a clinical-stage pharmaceutical
  company, Olema does not currently publish a developer-facing API, developer portal, SDKs, or public API documentation; this
  profile captures its corporate identity in the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/olema/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biopharmaceutical
- Oncology
- Healthcare
- Pharmaceuticals
- Clinical Trials
- Life Sciences
- Breast Cancer
common:
- type: DomainSecurity
  url: security/olema-domain-security.yml
- url: https://www.olema.com
  type: Website
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1